Current Month 2009
Article Features
  Meta-Analyses of Global Trials Finds in Favor of Aromatase Inhibitors
Breast Cancer Genome Shows Evolution, Instability of Cancer
Structure of Key Breast Cancer Target Unraveled
Age-Related Crossover in Breast Cancer Incidence Between Black and White Ethnic Groups Appears Robust
Breastfeeding May Prevent Breast Cancer
Cyclophilin B Is a Possible New Target for Treating Breast Cancer
Diet May Cut Risk of Breast Cancer Recurrence in Women Without Hot Flashes
Interpretation Time for Screening Digital Mammograms: Is it Efficient?
Structure of Key Breast Cancer Target Enzyme is Identified
Estrogen Pills May Benefit Some Women with Metastatic Breast Cancer
Reduced Breast Cancer Risk: Physical Activity After Menopause Pays Off
Understanding the Role for the Protein FAK in Breast Cancer
Team Finds Breast Cancer Gene Linked to Disease Spread
Modified Gene Targets Cancer Cells a Thousand Times More Often Than Healthy Cells
High Insulin Levels Raise Risk of Breast Cancer in Postmenopausal Women
Lapatinib Reduces Mammary Tumor Development in Mouse Model of Breast Cancer
Obesity Increases Lymphedema Risk for Breast Cancer Survivors
Risk-Reducing Salpingo-Oophorectomy for Women with BRCA Mutations
Researchers Identify New Protein That Triggers Breast Cancer
Chemopreventive Agents in Black Raspberries Identified
Breast Cancer Survivors Call for More ‘Survivorship Care’ from Primary Care Physicians
Researchers Find That Tamoxifen’s Power Comes from Endoxifen
Researchers Show How Certain Vegetables Combat Cancer
New Anti-Cancer Components of Extra-Virgin Olive Oil Revealed

Researchers Identify Risk Factors for Contralateral Breast Cancer

A preventive procedure to remove the unaffected breast in breast cancer patients with disease in one breast may only be necessary in patients who have high-risk features, as assessed by examining the patient's medical history and pathology of the breast cancer.

According to researchers at The University of Texas M. D. Anderson Cancer Center, this finding, published in the journal Cancer, may help physicians predict the likelihood of patients developing breast cancer in the opposite breast (contralateral breast cancer), stratify risk, and counsel patients on their treatment options.

"Women often consider contralateral prophylactic mastectomy (CPM) not because of medical recommendation, but because they fear having their breast cancer return," said Kelly Hunt, M.D., professor in the Department of Surgical Oncology at M. D. Anderson and lead author on the study. "Currently it is very difficult to identify which patients are at enough risk to benefit from this aggressive and irreversible procedure. Our goal was to determine what characteristics defined these high-risk patients to better inform future decisions regarding CPM."

Read More of the Main Article

Visit the Ezine

Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon